Bladder Cancer

A machine-learning approach to predict additional treatment after Bacillus Calmette-Guérin induction in non-muscle-invasive bladder cancer. June 4, 2026

10-yr Outcomes of Senior Clinical Fellowship in Robot-assisted Radical Cystectomy (RARC) with focus on Intracorporeal Ileal Conduit Urinary Diversion: Aggregated Learning Curve Assessment and Achievement of the EAU-Robotic Urology Section (ERUS) RARC Curr June 4, 2026

Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center. June 3, 2026

What's next for VI-RADS? Updates and future perspectives from the ACR VI-RADS steering committee. June 2, 2026

AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy. June 1, 2026

Decoding Immune Mechanisms in BCG-unresponsive Non-muscle Invasive Bladder Cancer. June 1, 2026

Real-world Patterns and Trends of Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer: Insights from a Large Prospective German Cohort. May 29, 2026

Proceedings of the first international NMIBC consensus classification meeting. May 28, 2026

Effective PD-1 checkpoint blockade in bladder cancer model requires tumor-draining lymph nodes and lymphocyte trafficking. May 27, 2026

Detection of Bladder Cancer in Patients with Microscopic Hematuria Using Oncuria-Detect: Results of a Prospective, Multicenter International Study - Beyond the Abstract May 26, 2026

An advanced in vitro bladder cancer model integrating bladder cancer spheroids into a healthy human urothelium for preclinical therapeutic testing. June 4, 2026

Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis. June 3, 2026

Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules. June 2, 2026

Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial. June 2, 2026

Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non-muscle-invasive Bladder Cancer: An Expert Consensus. June 1, 2026

Durvalumab and BCG Approved for Treating High-Risk NMIBC May 29, 2026

Computed tomography-derived extracellular volume fraction is associated with high-grade recurrence in non-muscle-invasive bladder cancer treated with intravesical gemcitabine and docetaxel. May 29, 2026

Trends in the diagnosis of variant bladder cancer: a national retrospective cohort analysis. May 28, 2026

Diagnostic performance of urinary tumor DNA in urothelial carcinoma: A systematic review and network meta-analysis. May 27, 2026

Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery. May 26, 2026

Page 1 of 602